Caleres (CAL) Q3 2025 earnings review
Acquisition Masks Weakness; Profitability Collapses
Caleres reported headline revenue growth of 6.6%, but this is entirely cosmetic. Organic growth was a meager 0.4%, and the bottom line has been decimated. The acquisition of Stuart Weitzman (SW) and persistent tariff headwinds crushed Adjusted EPS to $0.38 (down 69% YoY). More alarmingly, management guided for a loss in Q4 and slashed full-year Adjusted EPS expectations to just $0.55–$0.60—implies Q4 will wipe out ~40% of the year's accumulated earnings. While 'Lead Brands' are growing, the cost of this transition is currently overwhelming the P&L.
🐂 Bull Case
The core Brand Portfolio (excluding SW) grew organic sales 4.6%, with 'Lead Brands' up double digits. Market share gains in women's fashion footwear (+0.5%) suggest the product strategy is working despite macro headwinds.
Comp sales declined 1.2%, a marked improvement from the -3.4% in Q2 and -4.6% in Q1. Sequential improvement suggests the bleeding in the retail segment is slowing.
🐻 Bear Case
The FY25 Adjusted EPS guide ($0.55–$0.60) implies a Q4 Adjusted Loss of ~$0.35–$0.40. This is a dramatic deterioration from the $0.95 YTD earnings accumulated. The Stuart Weitzman integration is proving immediately and severely dilutive ($0.60–$0.65 FY impact).
Consolidated Adjusted Gross Margin fell 140bps to 42.7%. Brand Portfolio margins plummeted 350bps (GAAP) due to tariff pressures and inventory clearing. There is no immediate relief in sight for these structural costs.
⚖️ Verdict: 🔴
Bearish. While revenue stabilized, the quality of earnings has collapsed. The company is effectively trading profitable quarters for a loss-making integration (SW) and tariff battles. Until the Stuart Weitzman drag stabilizes and margins trough, the stock is dead money.
Key Themes
Stuart Weitzman: An Expensive Fixer-Upper
The acquisition closed in August and immediately turned into a heavy anchor. While it added $45.8M in sales, it dragged OpEx up significantly ($32.2M in SW-related SG&A). The guidance indicates SW alone will cause $0.60–$0.65 in EPS dilution for FY25. Management frames this as a 'transition year,' but the short-term financial damage is severe.
Tariffs Continued to Erode Margins
Gross margins are Reversing. Adjusted Gross Margin dropped 140bps YoY to 42.7%. Management explicitly cited 'continued tariff pressure' alongside the SW dilution. Brand Portfolio gross margins took the hardest hit, down 350bps YoY to 40.3% (GAAP), as the company struggles to offset sourcing costs with pricing power.
Famous Footwear: Less Bad is Good
Stabilizing. Famous Footwear (FF) sales fell 2.2% with comps down 1.2%. While still negative, this is a clear trajectory improvement from Q1 (-4.6%) and Q2 (-3.4%). Gross margins at FF (41.6%) were down 130bps, showing they are promoting heavily to maintain this volume, but the topline bleeding has slowed.
Organic Brand Growth
Accelerating. Excluding the noise from the SW acquisition, the legacy Brand Portfolio grew sales 4.6% YoY. Management cited 'double digit' growth in Lead Brands and market share gains in women's fashion footwear. This indicates the core product engine is actually performing well, but the financial results are masked by the acquisition and macro costs.
Inventory Build
Total inventory is up nearly 16% to $678M. While $77M of that is Stuart Weitzman, legacy inventory is still up 2.6% YoY while organic sales are barely flat (+0.4%). In a promotional environment with margins already under pressure, any excess inventory poses a risk to Q4 margins.
Other KPIs
Decelerating significantly from 7.9% in the prior year. The combination of gross margin pressure and higher SG&A (up 310bps as a % of sales) has crushed operating leverage.
Borrowings increased $116.5M vs prior year ($238.5M), largely to fund the SW acquisition. Liquidity remains adequate at $312M, but the balance sheet is more levered heading into a loss-making quarter.
Stable. DTC remains a high portion of sales, and 'owned eCommerce' grew double digits. This is a bright spot, as DTC typically commands higher gross margins, though currently offset by tariffs.
Guidance
Reversing. YTD Adjusted EPS is $0.95 ($0.22 Q1 + $0.35 Q2 + $0.38 Q3). The guidance implies a Q4 Adjusted Loss of approximately ($0.35) to ($0.40). This compares to $0.33 profit in 24Q4. The drop is driven by Stuart Weitzman integration and tariff headwinds.
Reversing to Loss. Management expects a full-year GAAP loss, driven by acquisition costs and restructuring. This is a stark contrast to the prior year's profitability ($3.09 GAAP EPS in FY24).
Higher than the ~23% guided in prior quarters, adding further pressure to the bottom line.
Key Questions
Stuart Weitzman Accretion Timeline
With SW causing ~$0.60+ dilution this year and driving a Q4 loss, specifically which quarter in FY26 do you expect the brand to turn breakeven or accretive to EPS?
Tariff Mitigation Lag
Gross margins in Brand Portfolio are down 350bps. How much of this is structural tariff cost vs. transient integration noise, and have you successfully passed any price increases to wholesale partners for Spring '26?
Inventory vs. Sales Mismatch
Excluding SW, inventory is up 2.6% while Famous Footwear sales are down. With a loss guided for Q4, is there a risk of further aggressive markdowns to clear this inventory, pushing margins even lower than implied?
Organic SG&A Trends
Selling and Administrative expenses were up $10M excluding SW. Given the sales environment, why are core expenses rising, and where is the leverage point?